Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: The MITEC study

Vascular Health and Risk Management

Volumn 5, Issue , 2009, Pages 175-183

  Baguet, Jean Philippe ^a   Asmar, R ^b   Valensi, P ^c   Nisse Durgeat, S ^d   Mallion, J M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Institut Cardiovasculaire   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d Laboratoires Takeda   (France)

Author keywords

Amlodipine; Candesartan; Carotid; Diabetes; Hypertension; Intima media thickness

Indexed keywords

AMLODIPINE BESYLATE; BIGUANIDE; CANDESARTAN HEXETIL; HYDROCHLOROTHIAZIDE; SULFONYLUREA; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; TETRAZOLE DERIVATIVE;

ADD ON THERAPY; ADULT; ADVERSE DRUG REACTION; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REMISSION; BLOOD PRESSURE; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DIABETIC ANGIOPATHY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FRANCE; HYPERTENSION; INTIMA; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; TUNICA MEDIA;

AGED; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; FRANCE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; TUNICA INTIMA; TUNICA MEDIA;

EID: 67449088325     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/vhrm.s3409     Document Type: Article

References (32)

1. Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O'Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol. 2003;23:1035-1041.
2. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol. 1997;146:483-494.
3. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
4. Zanchetti A. Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. J Hypertens. 1996; Suppl 14:S77-S80.
5. Wong M, Edelstein J, Wollman J, Bond MG. Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. Arterioscler Thromb. 1993;13:482-486.
6. Zanchetti A. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials. Clin Exp Hypertens. 1996;18:489-499.
7. Elmfeldt D, George M, Hubner R, Olofsson B. Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect. J Hum Hypertens. 1997;11:S49-S53.
8. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, et al; PREVENT Investigators. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation. 2000;102:1503-1510.
9. Terpstra WF, May JF, Smit AJ, Graeff PA, Meyboom-de Jong B, Crijns HJ. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens. 2004;22:1309-1316.
10. Stanton AV, Chapman JN, Mayet J, Sever PS, Poulter NR, Hughes AD, et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin Sci. 2001;101:455-464.
11. Valensi P, Baguet JP, Asmar R, Nisse-Durgeat S, Mallion JM. Effect of candesartan cilexetil on carotid intima-media thickness in hypertensive type 2 diabetic patients. MITEC study: design and baseline characteristics. Br J Diabetes Vasc Dis. 2007;7:18-24.
12. Guidelines Committee, 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
13. Baguet JP, Mallion JM, Moreau-Gaudry A, Noirclerc M, Peoc'h M, Siche JP. Relationships between cardiovascular remodeling and the pulse pressure in never treated hypertension. J Hum Hypertens. 2000;14:23-30.
14. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;7:1399-1406.
15. Ariff B, Zambanini A, Vamadeva S, Barratt D, Xu Y, Sever P, et al. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke. 2006;37:2381-2384.
16. Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990;21:1567-1572.
17. Ludwig M, Koft K, Rucker W, Hunter AM. Diagnosis of very early arteriosclerotic vascular wall changes using duplex sonography. Klin Wocheuschr. 1989;67:442-446.
18. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Arcabose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke. 2004;35:1073-1078.
19. Lonn EM, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, et al. Effects or ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E. Circulation. 2001;103:919-925.
20. Esposito K, Giugliano D, Nappo F, Marfella R. Regression of carotid atherosclerosis by control of postprandrial hyperglycemia in type 2 diabetes mellitus. Circulation. 2004;110:214-219.
21. Sidhu J, Kaposzta Z, Markus HS, Kaski JC. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscl Thromb Vasc Biol. 2004;24:930-934.
22. Simon A, Gariépy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes. Circulation. 2001;103:2949-2954.
23. Zanchetti A, Bond MG, Hennning M, Neiss A, Mancia G, Dal Palu C, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Circulation. 2002;106:2422-2427.
24. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 1998;16:949-961.
25. Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation. 2000;101:2601-2606.
26. Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS. Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke. 2004;35:2150-2154.
27. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101:1653-1659.
28. Christensen KL, Mulvany MJ. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens. 2001;19:1001-1006.
29. Ludwig M, Stapff M, Ribeiro A, Fritschka E, Tholl U, Smith RD, et al. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of 2 year, double blind, randomized, controlled study. Clin Ther. 2002;24:1175-1193.
30. Olsen MH, Wachtell K, Neland K, Bella JN, Rokkedal J, Dige-Petersen H, et al. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press. 2005;14:177-183.
31. Benetos A, Gautier S, Lafleche A, Topouchian J, Frangin G, Girerd X, et al. Blockade of Angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. J Vasc Res. 2000;37:8-15.
32. Vraamark T, Waldemar G, Strandgaard S, Paulson OB. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens. 1995;13:755-761.